Dr.-Brauns-Science-Prize for CRC 841 Scientist

13 June 2013
Professor Samuel Huber, principal investigator of a junior research group in the CRC 841, and Nicola Gagliani, PhD, Yale University, were awarded the Dr.-Liselotte-Brauns-Prize for Internal Medicine 2013. The science prize is conferred by the Hamburg foundation Dr. Liselotte und Dr. Karl-Robert Brauns and is endowed with 7,500 euros.

With the prize the foundation’s advisory board honoured Gagliani’s and Huber’s publication in Nature IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine . In their publication the two scientists describe a complex system in the intestine in which the intestinal flora, the immune system and epithelial cells interact to enable efficient wound healing and to suppress carcinogenesis. In this system Interleukin 22 (IL-22) and its soluble receptor Interleukin 22 binding protein (IL-22BP) play an important role. Within the CRC 841 Huber and his team investigate the role of IL-22 and IL-22BP during liver damage and the formation of liver cell cancer.